INTRODUCTION
The rheumatoid (RA) synovial tissue is characterized by infiltrating mononuclear cells, proliferating fibroblasts, and endothelial cells (1). The pathogenesis of synovial inflammation is mediated by both cellular and humoral interactions (2). A number of humoral mediators including cytokines such as interleukin-1 (IL-l) have been implicated in the evolution of the erosive arthritis associated with RA (3).
IL-1 is a 17-kDa cytokine that is produced by immune and nonimmune cells that has pleiotropic effects predominant form synthesized and released in the supernatants of stimulated cells (3, 4) . IL-1 can mediate a variety of effects that may contribute to the pathogenesis of RA. These effects include stimulation of endothelial cell-derived adherence proteins and production of fibroblast-derived prostaglandin E, and collagenase (4-S).
Joint inflammation and subsequent evolution to joint destruction may result from a delicate balance between the production of proinflammatory cytokines and cytokine inhibitors. Recently an IL-1 receptor antagonist protein, termed IRAP, has been isolated, purified, cloned, and expressed (9, 10). Exposure of peripheral blood monocytes to adherent IgG or granulocyte-macrophage colony stimulating factor promote the expression of IRAP from these cells (3, (11) (12) (13) . This protein functions as a competitive inhibitor of IL-1 at the level of the receptor. Although the production of IL-1 and IRAP by blood monocytes has been assessed, little is known regarding the production of this protein by cells obtained from inflammatory lesions. In this study we report that RA synovial tissue macrophages express mRNA for IL-1 and IRAP. Furthermore, RA synovial tissue macrophages and macrophage-derived synovial lining cells were demonstrated to have IL-l-p and IRAP antigen expression by immunohistochemical localization.
MATERIALS AND METHODS
Patients Studied and Cell Isolation on a variety of cells (3, 4) . Both IL-l-& and IL-l-p bind the same receptor; however, IL-l-p seems to be the Synovial tissues were obtained from eight patients with RA at the time of total joint replacement.
For " " comparison with the RA samples, synovial tissues 'This work was supported in part by NIH Grants HL31693, HL35276, HL02401, and DK38149, and Multipurpose Arthritis Cenwere obtained from six patients with osteoarthritis ter AR30692. Also, funds were provided by a V.A. Merit Review, dispase, DNAase, and collagenase as described previously (16, 17 
Northern Blot Analysis
Total cellular RNA was obtained from 2.5 x lo6 RA macrophages using a modification of Chirgwin and associates and . Briefly, cells were placed in a solution containing 25 mM Tris, pH 8.0, 4.2 M guanidine isothiocyanate, 0.5% Sarkosyl, and 0.1 M 2-mercaptoethanol.
After homogenization, the suspension was added to a solution containing an equal volume of 100 mM Tris, pH 8.0, 10 mM EDTA, and 1% SDS. The mixture was then extracted with chloroform-phenol and chloroform-isoamyl alcohol. The RNA was alcohol precipitated and the pellet dissolved in diethylpyrocarbonate-treated HzO. Total RNA was separated by Northern analysis using formaldehyde, 1% agarose gels, transblotted onto nitrocellulose, baked, prehybridized, and hybridized with a 32P-5' end-labeled oligonucleotide probe. A 30-mer oligonucleotide probe was synthesized using the published cDNA sequence for human-derived IRAP (10). The probe was complementary to nucleotides 438-468 and had the sequence 5'-TGT-GCA-GAG-GAA-CCA-ACC-GGG-GCA-GGC-GGC-3'.
A 30-mer oligonucleotide probe was synthesized using the published cDNA sequence for IL-l-8 (22). The probe was complementary to nucleotides 166 ,through 195 and had the sequence 5'-CGC-GGC-CTG-CCT-GAA-GCC-CTT-GCT-GTA-GTG-3'. Equivalent amounts of total RNA/gel were assessed by monitoring 28s and 18s rRNA.
Immunohistochemistry of Synovial Tissues
Antibodies used. Murine monoclonal anti-IL-l-8 and anti-IRAP (monoclonal antibody 14) were obtained from the Upjohn Co. (Kalamazoo, MI). Irrelevant mouse monoclonal antibodies were used as negative controls.
Immunoalkaline Phosphatase Staining
Immunoalkaline phosphatase staining was performed on formalin-fixed, paraffin-embedded RA synovial tissues (23). Tissue sections (5-7 km) mounted on poly+lysine-coated glass slides were deparaffinized and rehydrated in a graded series of xylene and ethanol solutions. The slides were treated with avidin for 15 min at room temperature followed by biotin (1:50 in goat blocking serum, room temperature) to block binding sites for these molecules (Vector Laboratories, Mountain View, CA). The slides were exposed to optimal dilutions of specific antibody or control antibody. After incubating for 20 min at 37°C the slides were rinsed with phosphate-buffered saline (X 31, overlaid with biotinylated secondary antibodies (Biogenex, San Ramon, CA), and .incubated another 20 min at 37°C followed by a phosphate-buffered saline (PBS) wash. Sections were treated with alkaline phosphataselabeled streptavidin (Biogenex) for 20 min at 37"C, rinsed in PBS, and overlaid with Vector red substrate chromogen containing 150 r&f NaCl and 10 mM levamisole (Vector) for 20 min at room temperature. Mayer's hematoxylin was used as a counterstain.
Microscopic Analysis of Immunohistochemistry
Each tissue was assigned an inflammatory score from 1 to 4, with 4 representing the greatest amount of mononuclear cell infiltrate.
In addition, a macrophage score was determined based on cell morphology to indicate the relative amount of macrophages present in a tissue. Macrophage scores ranged from 1 to 4, with 4 representing the greatest number of macrophages as previously described (24). Each tissue was reviewed by two pathologists and scored in a blinded fashion to determine the approximate percentage of macrophages, synovial lining cells, and endothelial cells reactive with the monoclonal antibodies.
Statistical Analysis
Correlation coefficients were determined by regression analysis. Differences between the mean values of groups was determined using a paired Student t test. P values co.05 were considered significant.
RESULTS

Gene Expression of IL-l -f3 and IRAP by RA Synovial
Tissue Macrophuges
Northern Blot analysis of mRNA isolated from purified macrophages from patients with RA is shown in Fig. 1 . Figure 1A shows steady state IRAP mRNA from two patients with RA. Figure 1B shows 18s and 28s rRNA corresponding to (A). Figure 1C shows steady state IL-l-p mRNA from the same patients along with 18s and 28s rRNA (D). Normal peripheral blood monocytes do not express IRAP (E and F) and require exogenous stimulation prior to expression of IRAP mRNA. In contrast, RA macrophages express both IRAP and IL-1 mRNA without exogenous stimuli.
Antigenic Expression of IL-l -f3 and IRAP by RA Synovial Tissue Macrophages
Since RA synovial macrophages were found to express both IL-l-l3 and IRAP mRNA, we determined whether this mRNA was translated to protein. Formalin-fixed, paraffin-embedded sections of synovial tissues were obtained from seven patients and six OA patients. Sections were immunostained with anti-IRAP (Table 1 ) and in selected cases with anti-IL-l-@. In general, the RA tissues had higher inflammatory scores than the OA tissues (2.3 + 0.3 versus 1.2 + 0.2) (means + SE). In addition, the numbers of macrophages present within the RA synovial tissues were Note. F, female; M, male; ND, not done. M+ = macrophage. "Tissues were assigned an inflammatory score with 1 being the least amount of inflammation and 4 being the greatest amount of infkmmation.
b Tissues were assigned a macrophage score with 1 being the least amount of macrophages and 4 being the greatest. greater than found within the OA tissues (3.1 + 0.3 versus 1.0). In RA, IRAP expression was noted in the synovial lining layer with 44 ? 16% of cells reacting with anti-IRAP (Table 1, Fig. 2 ). OA tissues also exhibited synovial lining layer IRAP reactivity (Table 1, Fig. 3) .
In RA synovial tissues, macrophages located in the subsynovial areas expressed IRAP, with 42 + 13% of macrophages staining positively as compared to only 9.6 + 4% of the macrophages obtained from OA immunostaining positive for IRAP. Although RA macrophages that were immunopositive for IRAP were principally distributed in the subsynovial region, perivascular macrophages were also immunopositive for IRAP. There was a positive relationship between the percentage of macrophages staining with anti-IRAP in RA and the macrophage score (r = 0.38) or the inflammatory score (r = 0.631, although neither correlation reached statistical significance. The minority of RA tissues displayed IRAP positive vascular endothelial cells. In addition, fibroblasts and lymphocytes located in the synovial tissues of RA patients did not express IRAP.
Representative RA synovial tissues were stained with anti-IL-l-l3 (Table 1 , Fig. 2 ). IL-l-l3 reactivity was present on the majority of macrophages (58 4 17%) and lining cells (68 + 13%). In contrast, a smaller percentage of macrophages in OA (26 + 8) were IL-l-l3 positive (Table 1, Fig. 3 ).
DISCUSSION
IL-1 has been implicated as an important factor mediating inflammation and joint destruction in RA (3). Attempts to measure bioactivity in human synovial fluids have often resulted in conflicting results, perhaps due to the presence of IL-l inhibitors in these fluids (3, 25, 26) . More recently, IL-l measured by ELISA demonstrated significantly increased levels of IL-l in RA synovial fluids (3, 25, 27) . Synovial fluid cells in vitro do not appear to produce increased levels of IL-l (3); however, rheumatoid synovial tissue in vitro synthesizes both IL-l-a and IL-l-l3 (28). Firestein and associates using in situ hybridization techniques have shown that approximately 10% of the cells dispersed from RA synovial tissues expressed IL-l-p mRNA. Furthermore, cells that were expressing constitutive IL-l-l3 were the macrophage-enriched OKMlpositive cell population (29). Interestingly, these studies failed to demonstrate IL-l-p mRNA expression from synovial fluid monocytes, suggesting potential disparate IL-l-l3 production between monocytes from synovial fluid and synovial tissue macrophages.
IRAP, a naturally occurring competitive inhibitor of IL-l at the level of the IL-l receptor, may serve to modulate IL-l effects. The relative amounts of IL-l-9 or IRAP synthesized by blood monocytes in culture depend upon the immunologic stimulus, and it appears that the same population of monocytes secrete both proteins (30). IRAP production is stimulated by adherence of monocytes to IgG, but this production can be counteracted by lipopolysaccharide stimulation of the cells (30). When peripheral blood monocytes are differentiated in culture to monocyte-derived macrophages, their production of IRAP increases, particularly in the presence of granulocyte-macrophage colony stimulating factor. In contrast, IL-l-p production is low in these cells (3, 11, 12, 13) . Malyak et al. have recently analyzed synovial fluids for the presence of IRAP by ELISA and found that IRAP levels are increased in RA as well as other arthritic disorders such as gouty arthritis (31). The origin of the cells liberating IRAP into synovial fluids was not examined.
In this study we have confirmed the production of IL-l-p by purified RA macrophages freshly isolated from the inflamed synovial tissue. In addition, we have shown that this same population of cells constitutively produce IRAP, unlike normal blood monocytes which exhibit little, if any, transcription of either IL-l-l3 or IRAP mRNA without in vitro stimulation.
Moreover, immunohistochemical localization of both IL-1 and IRAP antigens are found on RA synovial tissue macrophages as well as synovial lining cells. These findings indicate that tissues containing significant numbers of inflammatory cells, presumably secrete high levels of cytokines and contain an increased percentage of IRAP-positive macrophages. Furthermore, inflammatory cells within OA tissues such as macrophages are likely to secrete lower levels of some cytokines including IRAP. Thus, a greater percentage of RA, as compared to OA, subsynovial macrophages express IRAP. Furthermore, these data indicate that in the context of RA, the same population of synovial tissue macrophages can both mediate erosive joint destruction, via the production of IL-l, and also modulate this destruction by the production of IRAP in an autocrine and paracrine fashion. The net biological effect of IL-1 may be substantially regulated by the production of IRAP by synovial macrophages within the RA joint.
